Chemotherapy in Leprosy.
D000081:Acetamides / Q000627:therapeutic use; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D004195:Disease Models, Animal; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008713:Methimazole / Q000627:therapeutic use; D051379:Mice; D009166:Mycobacterium leprae / Q000187:drug effects; D010647:Phenyl Ethers / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D013890:Thiourea / Q000031:analogs & derivatives / Q000627:therapeutic use
D000081:Acetamides; D000814:Aniline Compounds; D010647:Phenyl Ethers; D013449:Sulfonamides; D013882:Thiosemicarbazones; D008713:Methimazole; D003622:Dapsone; D002991:Clofazimine; D013890:Thiourea; D012293:Rifampin